[Use of the CA 19-9 tumor marker in the diagnosis of pancreatic carcinoma].
The contribution of the tumor marker CA 19-9 to differential diagnosis between malignant and nonmalignant diseases of the pancreas was assessed in a group of 120 patients. On using border values of CA 19-9 80 U/ml, its sensitivity was found to be 84.4% and its specificity 84.8% for carcinomas of the pancreas. Correlation of CA 19-9 values with results of computer tomography and endogenous retrograde cholangiopancreatography in the patients studied yielded an over 80% accordance. In the light of the obtained results, the authors consider determination of CA 19-9 levels to be a suitable method supplementing the imaging examination methods in suspect carcinoma of the pancreas.
Kausitz
J
J
Subkatedra nukleárnej medicíny ILF v Bratislave, Slovakia.
Lesný
P
P
Belan
V
V
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis*; D002760:Cholangiopancreatography, Endoscopic Retrograde; D002908:Chronic Disease; D003937:Diagnosis, Differential; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D010195:Pancreatitis / Q000175:diagnosis; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed
D015295:Antigens, Tumor-Associated, Carbohydrate
Vyuzitie nádorového markera CA 19-9 pri diagnostike karcinómov pankreasu.